We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Wireless Connectivity Transforms POC Blood Glucose Testing

By LabMedica International staff writers
Posted on 07 Jul 2011
The National Health Service (NHS; United Kingdom) Trust has installed wireless blood glucose meters in wards, clinics, and theaters across all three of its acute hospital sites in Mid Yorkshire (United Kingdom).

Wireless devices, connected by intelligent IT systems are vital for patient safety and for meeting Clinical Pathology Accreditation (CPA) requirements for Point of Care (POC) testing.

The meters are linked wirelessly to the Hospital Information System (HIS) via the Roche POC data management solution, cobas IT 1000, allowing them to be managed centrally in accordance with national guidelines for POC devices.

In addition to transmitting patient results, Roche Diagnostic's (Burgess Hill, United Kingdom) blood glucose meter, Accu-Chek Inform II records quality control (QC) results, operator and patient details, consumable details, configuration information, and comments. More...
The data transmitted by the meters is managed by cobas IT 1000, which permits patient validation, operator recognition, and material lot tracking.

“Our new blood glucose testing system helps us to fulfill CPA requirements in a number of ways,” explained Tracey Eastwood, senior BMS responsible for POC testing within the Trust. “It provides a central record of all data, including QC records, which, in turn, provide an important audit trail. The system also enables us to manage reagents, calibrations, and quality control centrally. Centralized calibration of glucose meters has removed the risk of operator errors and the QC lockout feature ensures that operators perform the necessary QC activities at the required intervals, otherwise the meter cannot be used.”

While there is no cure for diabetes at the moment, management of the disease has become more effective.

Related Links:

National Health Service
Roche Diagnostics



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple oral swab detected blood-matched inflammatory signals in children with primary ciliary dyskinesia, offering a needle-free way to monitor inflammation during routine care (Image credit: Shutterstock)

Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. Symptoms can begin in the newborn period and progress to recurrent respiratory infections... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.